$88.34
4.08% yesterday
Nasdaq, Aug 12, 10:00 pm CET

ANI Pharmaceuticals, Inc. Stock price

$88.34
+23.15 35.51% 1M
+28.66 48.02% 6M
+33.06 59.80% YTD
+28.66 48.02% 1Y
+50.87 135.76% 3Y
+56.71 179.29% 5Y
+32.14 57.19% 10Y
-55.66 38.65% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+3.46 4.08%

Key metrics

Basic
Market capitalization
$1.9b
Enterprise Value
$2.4b
Net debt
$467.6m
Cash
$155.2m
Shares outstanding
21.7m
Valuation (TTM | estimate)
P/E
negative | 12.8
P/S
2.4 | 2.3
EV/Sales
2.9 | 2.9
EV/FCF
35.7
P/B
4.3
Financial Health
Equity Ratio
33.4%
Return on Equity
-4.7%
ROCE
2.7%
ROIC
3.6%
Debt/Equity
1.4
Financials (TTM | estimate)
Revenue
$811.5m | $807.3m
EBITDA
$119.7m | $206.1m
EBIT
$29.0m | $174.9m
Net Income
$-6.4m | $144.2m
Free Cash Flow
$66.6m
Growth (TTM | estimate)
Revenue
56.9% | 31.4%
EBITDA
7.1% | 192.0%
EBIT
-44.2% | 6,057.4%
Net Income
-120.9% | 815.5%
Free Cash Flow
-36.4%
Margin (TTM | estimate)
Gross
60.2%
EBITDA
14.7% | 25.5%
EBIT
3.6%
Net
-0.8% | 17.9%
Free Cash Flow
8.2%
More
EPS
$-0.3
FCF per Share
$3.1
Short interest
12.8%
Employees
897
Rev per Employee
$680.0k
Show more

Is ANI Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

ANI Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a ANI Pharmaceuticals, Inc. forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a ANI Pharmaceuticals, Inc. forecast:

Buy
86%
Hold
14%

Financial data from ANI Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
812 812
57% 57%
100%
- Direct Costs 323 323
68% 68%
40%
488 488
50% 50%
60%
- Selling and Administrative Expenses 326 326
88% 88%
40%
- Research and Development Expense 55 55
42% 42%
7%
120 120
7% 7%
15%
- Depreciation and Amortization 91 91
52% 52%
11%
EBIT (Operating Income) EBIT 29 29
44% 44%
4%
Net Profit -6.44 -6.44
121% 121%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about ANI Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ANI Pharmaceuticals, Inc. Stock News

Neutral
Seeking Alpha
4 days ago
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Christopher K. Mutz - Senior VP & Head of Rare Disease Nikhil Lalwani - President, CEO & Director Stephen P.
Neutral
GlobeNewsWire
5 days ago
BAUDETTE, Minn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the second quarter ended June 30, 2025.
Neutral
GlobeNewsWire
12 days ago
PRINCETON, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2025 financial results on Friday, August 8, 2025, prior to the market open.
More ANI Pharmaceuticals, Inc. News

Company Profile

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Head office United States
CEO Nikhil Lalwani
Employees 897
Founded 1996
Website www.anipharmaceuticals.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today